Erythropoietin receptor signal transduction requires protein geranylgeranylation

Journal of Pharmacology and Experimental Therapeutics

Volumn 316, Issue 1, 2006, Pages 403-409

  Hamadmad, Sumaya N ^a   Henry, Matthew K ^a,b   Hohl, Raymond J ^a  

^a UNIVERSITY OF IOWA   (United States)

^b DES MOINES UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; JANUS KINASE; MEVINOLIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; ERYTHROPOIETIN; GLYCOSYLATION; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; JANUS KINASE 2; LOVASTATIN; MEVALONIC ACID; MICE; POLYISOPRENYL PHOSPHATES; PROTEIN-TYROSINE KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, ERYTHROPOIETIN; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR;

EID: 29244482539     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.092510     Document Type: Article

References (40)

1. Arai A, Kanda E, and Miura O (2002) Rac is activated by erythropoietin or interleukin-3 and is involved in activation of the Erk signaling pathway. Oncogene 21:2641-2651.
2. Bar-Sagi D and Hall A (2000) Ras and Rho GTPases: a family reunion. Cell 103:227-238.
3. Carson DD and Lennarz WJ (1981) Relationship of dolichol synthesis to glycoprotein synthesis during embryonic development. J Biol Chem 256:4679-4686.
4. Casey PJ (1992) Biochemistry of protein prenylation. J Lipid Res 33:1731-1740.
5. Casey PJ (1995) Mechanisms of protein prenylation and role in G protein function. Biochem Soc Trans 23:161-166.
6. Chen C and Sytkowski AJ (2004) Erythropoietin regulation of Raf-1 and MEK: evidence for a Ras-independent mechanism. Blood 104:73-80.
7. Damen JE, Liu L, Cutler RL, and Krystal G (1993) Erythropoietin stimulates the tyrosine phosphorylation of Shc and its association with Grb2 and a 145-kDa tyrosine-phosphorylated protein. Blood 82:2296-2303.
8. Damen JE, Wakao H, Miyajima A, Krosl J, Humphries RK, Cutler RL, and Krystal G (1995) Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO (Eur Mol Biol Organ) J 14:5557-5568.
9. Fu HW and Casey PJ (1999) Enzymology and biology of CaaX protein prenylation. Recent Prog Horm Res 54:313-342.
10. Goldstein JL and Brown MS (1990) Regulation of the mevalonate pathway. Nature (Lond) 343:425-430.
11. Gu Y and Williams DA (2002) RAC2 GTPase deficiency and myeloid cell dysfunction in human and mouse. J Pediatr Hematol Oncol 24:791-794.
12. Hall A (1998) Rho GTPases and the actin cytoskeleton. Science (Wash DC) 279:509-514.
13. Holstein SA, Wohlford-Lenane CL, and Hohl RJ (2002) Consequences of mevalonate depletion. Differential transcriptional, translational, and post-translational upregulation of Ras, Rap1a, RhoA, and RhoB. J Biol Chem 277:10678-10682.
14. Hori Y, Kikuchi A, Isomura M, Katayama M, Miura Y, Fujioka H, Kaibuchi K, and Takai Y (1991) Post-translational modifications of the C-terminal region of the rho protein are important for its interaction with membranes and the stimulatory and inhibitory GDP/GTP exchange proteins. Oncogene 6:515-522.
15. Khosravi-Far R, Solski PA, Clark GJ, Kinch MS, and Der CJ (1995) Activation of Rac1, RhoA and mitogen-activated protein kinases is required for Ras transformation. Mol Cell Biol 15:6443-6453.
16. Koury MJ and Bondurant MC (1992) The molecular mechanism of erythropoietin action. Eur J Biochem 210:649-663.
17. Krantz SB (1991) Erythropoietin. Blood 77:419-434.
18. Lowy DR and Willumsen BM (1989) Protein modification: new clue to Ras lipid glue. Nature (Lond) 341:384-385.
19. Mackay DJ and Hall A (1998) Rho GTPases. J Biol Chem 273:20685-20688.
20. Manne V, Roberts D, Tobin A, O'Rourke E, De Virgilio M, Meyers C, Ahmed N, Kurz B, Resh M, Kung HF, et al. (1990) Identification and preliminary characterization of protein-cysteine farnesyltransferase. Proc Natl Acad Sci USA 87:7541-7545.
21. Mantha AJ, McFee KE, Niknejad N, Goss G, Lorimer IA, and Dimitroulakos J (2003) Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells. J Cancer Res Clin Oncol 129:631-641.
22. Miyazaki Y, Kuriyama K, Higuchi M, Tsushima H, Sohda H, Imai N, Saito M, Kondo T, and Tomonaga M (1997) Establishment and characterization of a new erythropoietin-dependent acute myeloid leukemia cell line, AS-E2. Leukemia 11:1941-1949.
23. Moomaw JF and Casey PJ (1992) Mammalian protein geranylgeranyltransferase. Subunit composition and metal requirements. J Biol Chem 267:17438-17443.
24. Nishida K, Kaziro Y, and Satoh T (1999) Anti-apoptotic function of Rac in hematopoietic cells. Oncogene 18:407-415.
25. Pelletier S, Duhamel F, Coulombe P, Popoff MR, and Meloche S (2003) Rho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors. Mol Cell Biol 23:1316-1333.
26. Penta K and Sawyer ST (1995) Erythropoietin induces the tyrosine phosphorylation, nuclear translocation and DNA binding of STAT1 and STAT5 in erythroid cells. J Biol Chem 270:31282-31287.
27. Qiu RG, Chen J, McCormick F, and Symons M (1995) A role for Rho in Ras transformation. Proc Natl Acad Sci USA 92:11781-11785.
28. Quelle FW, Wang D, Nosaka T, Thierfelder WE, Stravopodis D, Weinstein Y, and Ihle JN (1996) Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol Cell Biol 16:1622-1631.
29. Rowell CA, Kowalczyk JJ, Lewis MD, and Garcia AM (1997) Direct demonstration of geranylgeranylation and farnesylation of Ki-Ras in vivo. J Biol Chem 272:14093-14097.
30. Satoh K, Ichihara K, Landon EJ, Inagami T, and Tang H (2001) 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors block calcium-dependent tyrosine kinase Pyk2 activation by angiotensin II in vascular endothelial cells. Involvement of geranylgeranylation of small G protein Rap1. J Biol Chem 276:15761-15767.
31. Simon AR, Vikis HG, Stewart S, Fanburg BL, Cochran BH, and Guan KL (2000) Regulation of STAT3 by direct binding to the Rac1 GTPase. Science (Wash DC) 290:144-147.
32. Sinensky M (2000) Recent advances in the study of prenylated proteins. Biochim Biophys Acta 1484:93-106.
33. Stark WW Jr, Blaskovich MA, Johnson BA, Qian Y, Vasudevan A, Pitt B, Hamilton AD, Sebti SM, and Davies P (1998) Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells. Am J Physiol 275:L55-L63.
34. Torti M, Marti KB, Altschuler D, Yamamoto K, and Lapetina EG (1992) Erythropoietin induces p21ras activation and p120GAP tyrosine phosphorylation in human erythroleukemia cells. J Biol Chem 267:8293-8298.
35. Van de Donk NW, Kamphuis MM, van Kessel B, Lokhorst HM, and Bloem AC (2003) Inhibition of protein geranylgeranylation induces apoptosis in myeloma plasma cells by reducing Mcl-1 protein levels. Blood 102:3354-3362.
36. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, and Ihle JN (1993) JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227-236.
37. Xia Z, Tan MM, Wong WW, Dimitroulakos J, Minden MD, and Penn LZ (2001) Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells. Leukemia 15:1398-1407.
38. Youssoufian H, Longmore G, Neumann D, Yoshimura A, and Lodish HF (1993) Structure, function and activation of the erythropoietin receptor. Blood 81:2223-2236.
39. Zhang FL and Casey PJ (1996) Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem 65:241-269.
40. Zhong WB, Wang CY, Chang TC, and Lee WS (2003) Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis. Endocrinology 144:3852-3859.